Benefit-risk balance of advanced therapies in pediatric inflammatory bowel disease: evidence and gaps versus adults

Inflammatory Bowel Diseases · Published 2026-06-05 · DOI 10.1093/ibd/izag123

Authors (6)

Alexandre Mancheron, Christine Martinez-Vinson, Laurent Beaugerie, Bénédicte Pigneur, Jérôme Viala, Julien Kirchgesner

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mancheron, A., Martinez-Vinson, C., Beaugerie, L., et al. (2026). Benefit-risk balance of advanced therapies in pediatric inflammatory bowel disease: evidence and gaps versus adults. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag123

Related articles

• Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-Week Multicenter Study From the Porto Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition · Clinical Gastroenterology and Hepatology · 2026 · Cites or is cited by this article
• Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study · Inflammatory Bowel Diseases · 2026 · Same journal
• Mast cell–derived IL-13 as a driver of Crohn disease–associated intestinal fibrosis · Inflammatory Bowel Diseases · 2026 · Same journal
• Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments · Inflammatory Bowel Diseases · 2026 · Same journal
• Transmural healing is significantly associated with prevention of clinical relapse in Crohn’s disease · Inflammatory Bowel Diseases · 2026 · Same journal
• Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial · Inflammatory Bowel Diseases · 2026 · Same journal
• Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD · Inflammatory Bowel Diseases · 2026 · Same journal
• Inflammatory bowel disease in the aging population · Inflammatory Bowel Diseases · 2026 · Same journal
• Inflammatory bowel disease and risk of perineal injury in primiparous vaginal births: a retrospective cohort study · Inflammatory Bowel Diseases · 2026 · Same journal
• Interpreting oral dysbiosis during nutritional therapy in pediatric Crohn disease · Inflammatory Bowel Diseases · 2026 · Same journal